866

45 McCusker EJ, Richards F, Sillence D, et al. Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing. Clin Neurosci 2000; 7(1):38-41. https://www.ncbi.nlm.nih.gov/pubmed/10847649

46 Tranebjaerg L, Samson RA, Green GE. Jervell and Lange-Nielsen Syndrome. GeneReviews® 2002 July 29 [updated November 2014]. https://www.ncbi.nlm.nih.gov/books/NBK1405/

47 Bersudsky M, Rosenberg P, Rudensky B, et al. Lipopolysaccharides of a Campylobacter coli isolate from a patient with Guillain-Barré syndrome display ganglioside mimicry. Neuromuscul Disord 2000; 10:182-6. https://www.ncbi.nlm.nih.gov/pubmed/10734265

48 Janniger CK. Klippel-Trenaunay-Weber syndrome. Medscape. 2016. http://reference.medscape.com/article/1084257-overview

49 Vassalo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans cell histiocytosis. N Engl J Med 2000 342:1969-78. http://www.nejm.org/doi/full/10.1056/NEJM200006293422607

50 Beyerbach DM. Lown-Ganong-Levine syndrome. Medscape. 2015. http://emedicine.medscape.com/article/160097-overview

51 Quinlivan R, Vissing J, Hilton-Jones D, et al. Physical training for McArdle disease. Cochrane Database Syst Rev 2011; 12:CD007931. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007931.pub2/abstract

52 Quinlivan R, Martinuzzi A, Schoser B. Pharmacological and nutritional treatment for McArdle disease (glycogen storage disease type V). Cochrane Database Syst Rev 2010; 12:CD003458. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003458.pub4/abstract

53 Ault J. Marchiafava-Bignami disease. Medscape. 2016. http://emedicine.medscape.com/article/1146086-overview

54 Parker C. Eculizumab for paroxysmal nocturnal haemoglobinuria. Lancet 2009; 373(9665):759-67. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60001-5/abstract

55 Lambrecht NW. Ménétrier's disease of the stomach: a clinical challenge. Curr Gastroenterol Rep 2011; 13(6):513-17. https://www.ncbi.nlm.nih.gov/pubmed/21931998

56 Yamamoto M, Harada S, Ohara M, et al. Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome. Rheumatology (Oxford) 2005; 44(2):227-34. http://rheumatology.oxfordjournals.org/content/44/2/227.long

57 Asher RAJ. Munchausen's syndrome. Lancet 1951; 257:339-41. https://www.ncbi.nlm.nih.gov/pubmed/14805062

58 Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999; 341:137-41. http://www.nejm.org/doi/full/10.1056/NEJM199907153410301#t=article

59 Hatzimouratidis K, Eardley I, Giuliano F, et al. EAU guidelines on penile curvature. Eur Urol 2012; 62(3):543-52. https://www.ncbi.nlm.nih.gov/pubmed/22658761

60 Kim ED. Local therapies to heal the penis: fact or fiction? J Androl 2008; 30(4):384-90. https://www.ncbi.nlm.nih.gov/pubmed/19023141

61 Aomar Millán IF, Candel Erenas JM, et al. [Up-date of the diagnosis and treatment of vasospastic angina]. Rev Clin Esp 2008; 208(2):94-6. https://www.ncbi.nlm.nih.gov/pubmed/18261397

62 Keller KB, Lemberg L. Prinzmetal's angina. Am J Crit Care 2004; 13(4):350-4. https://www.ncbi.nlm.nih.gov/pubmed/15293589

63 Wanders RJA, Waterham HR, Leroy BP. Refsum disease. GeneReviews® 2006 March 20 [updated June 11 2015]. https://www.ncbi.nlm.nih.gov/books/NBK1353/

64 Fox RI. Sjögren's syndrome. Lancet 2005; 366:321-31. https://www.ncbi.nlm.nih.gov/pubmed/16039337

65 Worswick S, Cotliar J. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options. Dermatol Ther 2011; 24(2):207-18. https://www.ncbi.nlm.nih.gov/pubmed/21410610

66 Jayne DRW. Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis. CCJM 2002; 69(Suppl 2):SII110-5. http://www.ccjm.org/supplements/single-view/conventional-treatment-and-outcome-of-wegener-s-granulomatosis-and-microscopic-polyangiitis/0d8061df0951aa4829194e88a0a1ba6b.html

67 Kuo SH, Debnam JM, Fuller GN, et al. Wernicke's encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients. J Oncology 2009; 76(1):10-8. https://www.karger.com/Article/Abstract/174951

68 Marth T, Raoult D. Whipple's disease. Lancet 2003; 361(9353):239-46. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)12274-X/abstract

69 Auernhammer CJ, Göke B. Medical treatment of gastrinomas. Wien Klin Wochenschr 2007; 119(19-20):609-15. https://www.ncbi.nlm.nih.gov/pubmed/17985097

70 Anon. Listening to patients with rare diseases. Lancet 2009; 373:868. http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(09)60519-5.pdf

## Chapter 16: Radiology

No references for this chapter

## Chapter 17: Reference intervals

No references for this chapter

## Chapter 18: Practical procedures

1 Johnston AJ, Streater CT, Noorani R, et al. The effect of peripherally inserted central catheter (PICC) valve technology on catheter occlusion rates - The 'ELeCTRiC' study. J Vasc Access 2012; 13(4):421-5. https://www.ncbi.nlm.nih.gov/pubmed/22505280